L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBNLes informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Frais de port :
EUR 5,64
De Royaume-Uni vers Etats-Unis
Description du livre Paperback. Etat : Good. Features: * A convenient, authoritative, up-to-date guide for every clinician who treats patients with malignant disease * Covers every anticancer drug commonly used in Europe and the United States * Provides instant access to the latest clinical findings on anticancer drugs and their use in the management of adult and paediatric cancer patients * Also includes new advances in combined modality therapy and immunotherapy, as well as new anticancer drugs now being tested in laboratories around the world * Stephen K. Carter is Vice President, Anticancer Research, Bristol Myers Company, New York, New York, USA, Marie T. Bakowski is Director, Clinical Studies, Boehringer Ingelheim Limited, Bracknell, Berkshire, UK, Kurt Hellmann is Honorary Professor and Consultant, Radiotherapy and Oncology Department, Westminster Hospital, London, UK. The book has been read but remains in clean condition. All pages are intact and the cover is intact. Some minor wear to the spine. N° de réf. du vendeur GOR002561117
Description du livre Paperback. Etat : Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!. N° de réf. du vendeur S_331287829
Description du livre Etat : Good. Slight shelf ware on cover but otherwise fine. N° de réf. du vendeur 071802-1